105 related articles for article (PubMed ID: 9539249)
1. Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.
Southey MC; Batten LE; McCredie MR; Giles GG; Dite G; Hopper JL; Venter DJ
J Natl Cancer Inst; 1998 Apr; 90(7):532-6. PubMed ID: 9539249
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study.
Hsiao WC; Young KC; Lin SL; Lin PW
Breast Cancer Res; 2004; 6(3):R180-6. PubMed ID: 15084241
[TBL] [Abstract][Full Text] [Related]
3. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
Spurdle AB; Hopper JL; Dite GS; Chen X; Cui J; McCredie MR; Giles GG; Southey MC; Venter DJ; Easton DF; Chenevix-Trench G
J Natl Cancer Inst; 2000 Oct; 92(20):1674-81. PubMed ID: 11036113
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.
Spurdle AB; Dite GS; Chen X; Mayne CJ; Southey MC; Batten LE; Chy H; Trute L; McCredie MR; Giles GG; Armes J; Venter DJ; Hopper JL; Chenevix-Trench G
J Natl Cancer Inst; 1999 Jun; 91(11):961-6. PubMed ID: 10359549
[TBL] [Abstract][Full Text] [Related]
5. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
Ishitobi M; Miyoshi Y; Ando A; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
Clin Cancer Res; 2003 Apr; 9(4):1376-80. PubMed ID: 12684407
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
Akisik E; Dalay N
Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
[TBL] [Abstract][Full Text] [Related]
7. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
8. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
Cai Q; Gao YT; Wen W; Shu XO; Jin F; Smith JR; Zheng W
Cancer Res; 2003 Sep; 63(18):5727-30. PubMed ID: 14522892
[TBL] [Abstract][Full Text] [Related]
9. Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis.
Vasconcelos A; Medeiros R; Veiga I; Pereira D; Carrilho S; Palmeira C; Azevedo C; Lopes CS
Breast J; 2002; 8(4):226-9. PubMed ID: 12100115
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
Roodi N; Bailey LR; Kao WY; Verrier CS; Yee CJ; Dupont WD; Parl FF
J Natl Cancer Inst; 1995 Mar; 87(6):446-51. PubMed ID: 7861463
[TBL] [Abstract][Full Text] [Related]
11. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
[TBL] [Abstract][Full Text] [Related]
12. Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer.
Curran JE; Lea RA; Rutherford S; Weinstein SR; Griffiths LR
Int J Cancer; 2001 Jul; 95(4):271-5. PubMed ID: 11400122
[TBL] [Abstract][Full Text] [Related]
13. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years.
Firgaira FA; Seshadri R; McEvoy CR; Dite GS; Giles GG; McCredie MR; Southey MC; Venter DJ; Hopper JL
J Natl Cancer Inst; 1999 Dec; 91(24):2107-11. PubMed ID: 10601382
[TBL] [Abstract][Full Text] [Related]
14. An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer.
Lehrer SP; Schmutzler RK; Rabin JM; Schachter BS
Breast Cancer Res Treat; 1993; 26(2):175-80. PubMed ID: 8219254
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
[TBL] [Abstract][Full Text] [Related]
16. [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].
Iwase H; Kobayashi S; Iwata H; Yamashita T; Ito K; Toyama T; Hara Y; Greenman J; Mathew CG
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():61-5. PubMed ID: 8702313
[TBL] [Abstract][Full Text] [Related]
17. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
19. Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors.
Iwase H; Greenman JM; Barnes DM; Hodgson S; Bobrow L; Mathew CG
Cancer Lett; 1996 Nov; 108(2):179-84. PubMed ID: 8973592
[TBL] [Abstract][Full Text] [Related]
20. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
